Medical Science Liaison
AbbottFull Time
Mid-level (3 to 4 years), Senior (5 to 8 years)
Key technologies and capabilities for this role
Common questions about this position
This is a fixed term hybrid role, covering allocated key centres across UK and Ireland.
This is a fixed term opportunity likely to last up to 12 months, commencing in March 2026.
Key responsibilities include developing therapy area knowledge, engaging with KOLs and healthcare professionals, delivering scientific presentations, providing medical information services, and facilitating clinical research initiatives.
Ferring fosters an entrepreneurial, innovative, and collaborative environment where teams share ideas, respect diverse contributions, and work together to make a difference in patients' lives.
Strong candidates will have deep knowledge of therapy areas like reproductive health, gastroenterology, or urology, experience engaging with KOLs, and skills in delivering scientific presentations and supporting medical strategies.
This information is not specified in the job description.
Develops therapies for neurological disorders
Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.